Predict your next investment

Venture Capital
efungcapital.com

See what CB Insights has to offer

Investments

51

Portfolio Exits

6

Funds

2

About EFung Capital

EFung Capital focuses on biomedicine investments.

EFung Capital Headquarter Location

505 China Resources Building 2666 Keyuan South Road, Nanshan District

Shenzhen, Guangdong, 518026,

China

+86-755-8203-6140

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest EFung Capital News

DealShot: 12 Deals Worth $230 Million Including Efung Capital, Lilly Asia And More

Aug 27, 2021

Introducing Finley, the fintech newsbot from China Money Network !Using state-of-the-art machine learning technologies, Finley scours the globe for immediately usable data about the latest private equity deals, venture capital funding rounds, and business expansions happening in China.Finley asks: Who's buying whom? What company just raised new capital? What is the relationship among the parties?Then Finley uses his very real artificial intelligence to decipher that unstructured data to write news articles for you to read.So from unstructured data to a news story you can understand, China Money Network's Finley is your fintech newsbot business partner! RELATED NEWS

EFung Capital Investments

51 Investments

EFung Capital has made 51 investments. Their latest investment was in JSI Pharma as part of their Series B on November 11, 2021.

CBI Logo

EFung Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/15/2021

Series B

JSI Pharma

No

7

11/11/2021

Seed VC - II

Gluetacs Therapeutics

$15.65M

Yes

11

10/19/2021

Series B - III

Thermo Scientific

$31.33M

Yes

5

9/27/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

9/13/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/15/2021

11/11/2021

10/19/2021

9/27/2021

9/13/2021

Round

Series B

Seed VC - II

Series B - III

Series A - II

Series A - II

Company

JSI Pharma

Gluetacs Therapeutics

Thermo Scientific

Subscribe to see more

Subscribe to see more

Amount

$15.65M

$31.33M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

11

5

10

10

EFung Capital Portfolio Exits

6 Portfolio Exits

EFung Capital has 6 portfolio exits. Their latest portfolio exit was Harbour BioMed on December 10, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/10/2020

IPO

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

12/10/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

EFung Capital Fund History

2 Fund Histories

EFung Capital has 2 funds, including Shenzhen Qianhai Efung Taihe Equity Investment Fund LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Shenzhen Qianhai Efung Taihe Equity Investment Fund LP

Diversified Private Equity

1

Shenzhen Efung Ruiyi Investment Center LP

Subscribe to see more

$99M

10

Closing Date

Fund

Shenzhen Qianhai Efung Taihe Equity Investment Fund LP

Shenzhen Efung Ruiyi Investment Center LP

Fund Type

Diversified Private Equity

Subscribe to see more

Status

Amount

$99M

Sources

1

10

EFung Capital Team

1 Team Member

EFung Capital has 1 team member, including current Chief Financial Officer, Min Yang.

Name

Work History

Title

Status

Min Yang

Chief Financial Officer

Current

Name

Min Yang

Work History

Title

Chief Financial Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.